iBio, Inc.
IBIO
$2.22
$0.115.21%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -50.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -50.00% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -50.00% | |||
| SG&A Expenses | 106.52% | 15.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 56.09% | 12.10% | |||
| Operating Income | -58.71% | -14.49% | |||
| Income Before Tax | -57.22% | -10.79% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -57.22% | -10.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -57.22% | -10.79% | |||
| EBIT | -58.71% | -14.49% | |||
| EBITDA | -61.58% | -15.19% | |||
| EPS Basic | 68.82% | 18.92% | |||
| Normalized Basic EPS | 68.81% | 18.91% | |||
| EPS Diluted | 68.82% | 18.92% | |||
| Normalized Diluted EPS | 68.81% | 18.91% | |||
| Average Basic Shares Outstanding | 404.08% | 36.66% | |||
| Average Diluted Shares Outstanding | 404.08% | 36.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||